GO and KEGG analysis results of PA against osteosarcoma. by Zeyu Zhan (22305085)

Subjects:

Potential targets and PPI networks of PA against osteosarcoma. by Zeyu Zhan (22305085)

Subjects:

PA triggers autophagy in osteosarcoma cells. by Zeyu Zhan (22305085)

Subjects:

PA-induced apoptosis in osteosarcoma cells. by Zeyu Zhan (22305085)

Subjects:

PA inhibits the proliferation of osteosarcoma cells. by Zeyu Zhan (22305085)

Subjects:

Molecular Docking Analysis of PA with its core target. by Zeyu Zhan (22305085)

Subjects:

Visceral examination of Bouin’s solution fixed 20-day old rat fetuses treated with <i>U.simensis</i> essential oil: (A) un-sectioned fetus, (B) coronal section of head, V- ventricl... by Bickes Wube (21678222)

Subjects:

Summary of significance levels for comparison of surgical segment ROM between different test groups. by Jia Zhu (135506)

Subjects:

Coal mine fire area sampling data. (a) temperature, (b) humidity, (c) total nitrogen, (d) total phosphorus, and (e) available potassium (Republished from Desheng Xie under a CC BY... by Desheng Xie (21439869)

Subjects:

Percentage distribution of TPM by survey year. by Mobolaji M. Salawu (11792411)

Subjects:

Beta diversity of soil bacteria in different disturbed areas of CG by PCoA. by Bianhua Zhang (22430652)

Subjects: “…aggregation coefficient decreased…”

Cyclosporin A significantly reduces the survival rate and completely inhibits the formation of multicellular aggregates in tolerant strains under caspofungin stress. by Yongqin Wu (272012)

“…<p>(A) Cyclosporin A decreases the survival rate of tolerant strains under caspofungin. …”

AUC of various models to predict imeglimin efficacy for liver function evaluated by ROC curves. by Naruyoshi Gyoutoku (22537831)

Subjects:

Logistic regression analysis to predict the efficacy for liver function. by Naruyoshi Gyoutoku (22537831)

Subjects:

Comparison in baseline variables between efficacy group and non-efficacy group. by Naruyoshi Gyoutoku (22537831)

Subjects:

Comparison of ALT (A), AST (B), and Fib-4 index (C) before and after imeglimin treatment in ALT ≥ 25 IU/L and ALT < 25IU/L groups. by Naruyoshi Gyoutoku (22537831)

Subjects:

Clinical characteristics at baseline and at the end of the study. by Naruyoshi Gyoutoku (22537831)

Subjects:

Survival function analysis of mortality for Viral load status and Treatment Interruption status. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Multivariate Cox proportional hazard analysis ratio of patient factors associated with treatment outcomes in HIV care, 2020-2022. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Survival function analysis of treatment Interruption for Viral load status and BMI status. by Ekerette Emmanuel Udoh (7326194)

Subjects: